Vitiligo Market Outlook
The increasing prevalence of vitiligo, affecting roughly 1% of the global population or approximately 70 million people, is a key driver of the drug pipeline. In the United States alone, an estimated 3 million individuals are impacted, many of whom face significant psychological and social challenges. Vitiligo Drug Pipeline Analysis This rising incidence...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
Urdu
Amharic
Swahili
